{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1196.465",
  "meta": {
    "versionId": "15",
    "lastUpdated": "2021-09-09T01:01:05.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.465",
  "version": "20210909",
  "name": "Cromolyn Inhalant Preparations",
  "status": "active",
  "date": "2021-09-09T01:01:05-04:00",
  "publisher": "NHLBI Implementation Science and Health Care Innovation Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "309548",
            "display": "cromolyn sodium 20 MG Inhalation Powder"
          },
          {
            "code": "831246",
            "display": "cromolyn sodium 10 MG/ML Inhalation Solution"
          }
        ]
      }
    ]
  }
}